These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12379365)

  • 21. Anti-idiotypic antibodies: from regulation to therapy of factor VIII inhibitors.
    Saint-Remy JM; Jacquemin MG; Gilles JG
    Vox Sang; 1999; 77 Suppl 1():21-4. PubMed ID: 10529681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physiopathology of catalytic antibodies: the case for factor VIII-hydrolyzing immunoglobulin G.
    Wootla B; Dasgupta S; Mallet V; Kazatchkine MD; Nagaraja V; Friboulet A; Kaveri SV; Lacroix-Desmazes S
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):229-34. PubMed ID: 16651863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hematopoietic stem cells encoding porcine factor VIII induce pro-coagulant activity in hemophilia A mice with pre-existing factor VIII immunity.
    Doering CB; Gangadharan B; Dukart HZ; Spencer HT
    Mol Ther; 2007 Jun; 15(6):1093-9. PubMed ID: 17387335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of an FVIII Inhibitor in a Mild Hemophilia Patient with a Phe595Cys Mutation.
    Yamanouchi J; Tokumoto D; Ikeda Y; Maruta M; Kaneko M; Hato T; Yasukawa M
    Intern Med; 2018 Nov; 57(21):3179-3182. PubMed ID: 29877292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. False-positive results in ELISA-based anti FVIII antibody assay may occur with lupus anticoagulant and phospholipid antibodies.
    Sahud M; Zhukov O; Mo K; Popov J; Dlott J
    Haemophilia; 2012 Sep; 18(5):777-81. PubMed ID: 22458845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation of factor-VIII-depleted plasma with antibodies and its use for the assay of factor VIII.
    Rothschild C; Amiral J; Adam M; Meyer D
    Haemostasis; 1990; 20(6):321-8. PubMed ID: 2129163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid acquisition of immunologic tolerance to factor VIII and disappearance of anti-factor VIII IgG4 after prophylactic therapy in a hemophilia A patient with high-titer factor VIII inhibitor.
    Moorehead PC; Thibeault L; Tuttle A; Grabell J; Dwyre L; Silva M; James P; Lillicrap D
    J Pediatr Hematol Oncol; 2015 May; 37(4):e220-2. PubMed ID: 25411864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful immune tolerance induction with high-dose coagulation factor VIII and intravenous immunoglobulins in a patient with congenital hemophilia and high-titer inhibitor of coagulation factor VIII despite unfavorable prognosis for the therapy.
    Kubisz P; Plamenová I; Hollý P; Stasko J
    Med Sci Monit; 2009 Jun; 15(6):CS105-11. PubMed ID: 19488019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Restricted epitope specificity of anti-FVIII antibodies that appeared during a recent outbreak of inhibitors.
    Gilles JG; Peerlinck K; Arnout J; Vermylen J; Saint-Remy JM
    Thromb Haemost; 1997 May; 77(5):938-43. PubMed ID: 9184406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Localization of human factor FVIII inhibitor epitopes to two polypeptide fragments.
    Fulcher CA; de Graaf Mahoney S; Roberts JR; Kasper CK; Zimmerman TS
    Proc Natl Acad Sci U S A; 1985 Nov; 82(22):7728-32. PubMed ID: 2415970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IgG subclasses of FVIII inhibitors in an argentine cohort of severe hemophilia A patients: Analysis by flow cytometry.
    Irigoyen MB; Primiani L; Felippo M; Candela M; de Bracco MME; Galassi NV
    Int J Lab Hematol; 2017 Dec; 39(6):569-576. PubMed ID: 28612430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-factor VIII antibodies: a 2005 update.
    Lavigne-Lissalde G; Schved JF; Granier C; Villard S
    Thromb Haemost; 2005 Oct; 94(4):760-9. PubMed ID: 16270627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factor VIII Ise (R2159C) in a patient with mild hemophilia A, an abnormal factor VIII with retention of function but modification of C2 epitopes.
    Suzuki H; Shima M; Arai M; Kagawa K; Fukutake K; Kamisue S; Nakai H; Morichika S; Tanaka I; Inoue M; Gale K; Tuddenham EG; Yoshioka A
    Thromb Haemost; 1997 May; 77(5):862-7. PubMed ID: 9184393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bortezomib delays the onset of factor VIII inhibitors in experimental hemophilia A, but fails to eliminate established anti-factor VIII IgG-producing cells.
    Meslier Y; André S; Dimitrov JD; Delignat S; Bayry J; Kaveri SV; Lacroix-Desmazes S
    J Thromb Haemost; 2011 Apr; 9(4):719-28. PubMed ID: 21251202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Innovative use of porcine factor VIII:C for immune tolerance induction.
    Hay CR
    Am J Med; 1991 Nov; 91(5A):27S-29S. PubMed ID: 1746593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blockade of CD40/CD40 ligand interactions prevents induction of factor VIII inhibitors in hemophilic mice but does not induce lasting immune tolerance.
    Reipert BM; Sasgary M; Ahmad RU; Auer W; Turecek PL; Schwarz HP
    Thromb Haemost; 2001 Dec; 86(6):1345-52. PubMed ID: 11776297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoblot analysis shows changes in factor VIII inhibitor chain specificity in factor VIII inhibitor patients over time.
    Fulcher CA; Lechner K; de Graaf Mahoney S
    Blood; 1988 Oct; 72(4):1348-56. PubMed ID: 2458782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Development of FVIII Inhibitors in Relation to IL10 Gene Polymorphism in Hemophilia A Egyptian Pediatric Patients.
    Sadek H; Youssry I; Ibrahim NSE; Abou-Elalla AA; Atef G; Mousa SM
    Fetal Pediatr Pathol; 2017 Jun; 36(3):184-189. PubMed ID: 28574805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-factor VIII antibodies in brothers with haemophilia A share similar characteristics.
    Kahle J; Orlowski A; Stichel D; Healey JF; Parker ET; Donfield SM; Astermark J; Berntorp E; Lollar P; Schwabe D; Königs C
    Haemophilia; 2017 Mar; 23(2):292-299. PubMed ID: 27862687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of antibodies induced by human factor VIII in a murine knockout model of hemophilia A.
    Reipert BM; Ahmad RU; Turecek PL; Schwarz HP
    Thromb Haemost; 2000 Nov; 84(5):826-32. PubMed ID: 11127864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.